| 1. 潘迪康，王辉，武森森，王聪，郭建明，谷涌泉*.Association of serum 25-hydroxyvitamin D concentration with all-cause and cause-specific mortality in hypertensive patients. .2024.34（5）. .SCI(含SCIE) |
| 2. 潘迪康，郭聚龙，武森森，王辉，王聪，谷涌泉*.Association of secondhand smoke exposure with all-cause mortality and cardiovascular death in patients with hypertension: Insights from NHANES. .2024.1779-1786. .SCI(含SCIE) |
| 3. 潘迪康，王辉，武森森，郭建明，郭连瑞，谷涌泉*.Mapping the blueprint of artificial blood vessels research: a bibliometric analysis. .2024.doi.org/10.1097/JS9.0000000000001877. .SCI(含SCIE) |
| 4. 潘迪康，郭聚龙，苏志向，孟文卓，王聪，郭建明，谷涌泉*.Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study. .2024.99. .SCI(含SCIE) |
| 5. 潘迪康，王辉，武森森，宁雅婵，郭建明，王聪，谷涌泉*.Unveiling the Hidden Burden: Estimating All-Cause Mortality Risk in Older Individuals with Type 2 Diabetes. .2024.1741878. .SCI(含SCIE) |
| 6. 潘迪康，王辉，武森森，郭建明，郭连瑞，谷涌泉*.Association of prognostic nutritional index with peripheral artery disease in US adults: a cross-sectional study. .2024.24（1）. .SCI(含SCIE) |
| 7. 吴中俭，周正统，卞春建，郭连瑞，佟铸，郭建明，齐立行，崔世军，张成超，陈奕龙，黄伟，谷涌泉*.In vivo evaluation of safety and performance of a tapered nitinol venous stent with inclined proximal end in an ovine iliac venous model. .2024.14（1）. .SCI(含SCIE) |
| 8. 隗立兵，潘迪康，武森森，王辉，郭连瑞，谷涌泉*.A glimpse into the future: revealing the key factors for survival in cognitively impaired patients. .2024.16. .SCI(含SCIE) |
| 9. 高欣怡，郭聚龙，潘迪康，谷涌泉*.Treatment Strategies for Asymptomatic Carotid Stenosis: A Systematic Review and Bayesian Network Meta-Analysis. .2024.doi.org/10.1227/ons.0000000000001251. .SCI(含SCIE) |
| 10. Ning Y, Pan D, Guo J, GU Y*.Association of prognostic nutritional index with the risk of all-cause mortality and cardiovascular mortality in patients with type 2 diabetes: NHANES 1999-2018.. .2023.11(5). .SCI(含SCIE) |
| 11. 孟文卓，郭聚龙，潘迪康，郭连瑞*，谷涌泉*.Intravascular Ultrasound-Guided Versus Angiography-Guided Endovascular Therapy for Femoropopliteal Artery Disease: A Scoping Review. .2023.暂无. .SCI(含SCIE) |
| 12. 潘迪康，郭聚龙，苏志向，王靖宇，武森森，谷涌泉*，郭建明*.Association of the controlling nutritional status score with all-cause mortality and cancer mortality risk in patients with type 2 diabetes: NHANES 1999–2018. .2023.15（1）. .SCI(含SCIE) |
| 13. 潘迪康、郭聚龙，苏志向，孟文卓，王聪，郭建明，谷涌泉*.Safety and Efficacy of Excimer Laser Atherectomy Combined with a Drug-Coated Balloon in De Novo Femoral Popliteal Artery Disease: A Retrospective Study. .2023.99（1）. .SCI(含SCIE) |
| 14. 潘迪康、郭聚龙，苏志向，孟文卓，王靖宇，郭建明，谷涌泉*.Efficacy and Safety of Atherectomy Combined With Balloon Angioplasty vs Balloon Angioplasty Alone in Patients With Femoro-Popliteal Lesions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. .2023.4（1）. .SCI(含SCIE) |
| 15. 成津，王聪，郭连瑞 ，谷涌泉*.Development of heparinized and hepatocyte growth factor-coated acellular scaffolds using porcine carotid arteries. .2023.25. .SCI(含SCIE) |
| 16. 谷涌泉，王辉.如何提高下肢动脉粥样硬化闭塞症腔内治疗术后的通畅率？. .2023.9（3）. .CSCD |
| 17. Pan D, Wang J, Guo J, Gu Y*.Impact of geriatric nutritional risk index on prognosis in peripheral artery disease patients undergoing endovascular therapy. .2023.;25(5):. .SCI(含SCIE) |
| 18. 郭聚龙，宁雅婵，潘迪康，武森森，高喜翔，王聪，郭连瑞*，谷涌泉*.Identification of potential hub genes and 1 regulatory networks of smoking-related 2 endothelial dysfunction in atherosclerosis 3 using bioinformatics analysis. .2023.11（1）. .SCI(含SCIE) |
| 19. 苏志向，谷涌泉*.Pharmacotherapy in Clinical Trials for Abdominal Aortic Aneurysms: A Systematic Review and Meta-Anal. .2022.28. .SCI(含SCIE) |
| 20. 苏志向，谷涌泉*.Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoro. .2022.1-6. .SCI(含SCIE) |
| 21. 郭聚龙，郭连瑞，谷涌泉*.The efficacy and safety of different endovascular modalities for infrapopliteal arteries lesions: A network meta-analysis of randomized controlled trials. .2022.993290. .SCI(含SCIE) |
| 22. 郭聚龙，郭连瑞，谷涌泉*.Identification of hub genes and regulatory networks in histologically unstable carotid atherosclerotic plaque by bioinformatics analysis. .2022.15，145. .SCI(含SCIE) |
| 23. 郭聚龙，郭连瑞，谷涌泉*.Risk factors for in-stent restenosis after vertebral artery stenting of V1 segment： A systematic review and meta‐analysis. .2022.2022,1-11. .SCI(含SCIE) |
| 24. 苏志向，谷涌泉*.Biological small-calibre tissue engineered blood vessels developed by electrospinning and in-body ti. .2022.33. .SCI(含SCIE) |
| 25. 李杨，谷涌泉*.腘动脉松解术治疗腘动脉陷迫综合征一例并文献复习. .2022.17（3）. .SCI(含SCIE) |
| 26. 王辉，谷涌泉*.准分子激光斑块消蚀术联合药物涂层球囊治疗股腘动脉支架内再狭窄研究进展. .2022.31（5）. .CSCD |
| 27. 吴中俭，谷涌泉*.超声引导介入治疗外周动脉硬化闭塞症. .2022.22（5）. .CSCD |
| 28. 谷涌泉.自体干细胞移植规范化治疗下肢慢性缺血性疾病专家共识（2021）. .2021.11/5. .CSCD |
| 29. 郭连瑞，谷涌泉*.球扩式覆膜支架在外周动脉硬化闭塞性病变治疗中的应用：4例报告. .2021.30/2. .CSCD |
| 30. 成津，谷涌泉*.脱细胞技术在组织工程血管中的应用进展. .2021.40/1. .CSCD |
| 31. 王春梅，谷涌泉*.颈动脉支架植入术后管理. .2021.30/1. .CSCD |
| 32. 谷涌泉，张庆林.pUDK-HGF Gene Therapy to Relieve CLI Rest Pain and Ulcer： A Phase II, Double-Blind, Randomized Placebo-Controlled Trial. .2021.32. .SCI(含SCIE) |
| 33. 张元国，谷涌泉*.Design and characterization of small-diameter tissue-engineered blood vessels constructed by electrospun polyurethane-core and gelatin-shell coaxial fiber. .2021.12/1. .SCI(含SCIE) |
| 34. 成津，谷涌泉*.Decellularization of porcine carotid arteries using low-concentration sodium dodecyl sulfate. .2021.44/7. .SCI(含SCIE) |
| 35. 张成超，谷涌泉*.外周动脉血管断裂四例诊治分析. .2020.19（9）. .CSCD |
| 36. 张成超，谷涌泉*.开环支架治疗严重迂曲颈动脉重度狭窄病例观察. .2020.48（8）. .CSCD |
| 37. 张成超，谷涌泉*.补救性支架在脾动脉瘤介入治疗中的应用体会1例. .2020.17(2). .CSCD |
| 38. 李杨 ，谷涌泉*.准分子激光消蚀辅助普通球囊扩张治疗膝下动脉病变临床研究. .2020.29（1）. .CSCD |
| 39. 谷涌泉.近肾腹主动脉瘤的外科治疗. .2020.33（4）. .CSCD |
| 40. 刘一人 谷涌泉*.头臂型大动脉炎血管旁路术与腔内治疗的疗效分析. .2020.20（7）. .CSCD |
| 41. 郭连瑞，谷涌泉*.糖尿病足血管病变的腔内治疗. .2020.5（4）. .CSCD |
| 42. 谷涌泉.中国糖尿病足诊治指南. .2020.48（1）. .CSCD |
| 43. 李骥 ，谷涌泉*.Characterization of a heparinized decellularized scaffold and its effects on mechanical and structural properties. .2020.31/8. .SCI(含SCIE) |
| 44. 宋礼坡，谷涌泉*.Long-term outcomes of axillary to carotid bypass for symptomatic patients with chronic common carotid artery occlusion. .2020.72/2. .SCI(含SCIE) |
| 45. 高喜翔，谷涌泉*.Successful Treatment of Acquired Arteriovenous Fistulas after Iliac Vein Thrombosis. .2020.499. .SCI(含SCIE) |
| 46. 李立强，谷涌泉*.Collagen IV, a promising serum biomarker for evaluating the prognosis of revascularization in a 2-kidney, 1-clip hypertensive rat model. .2020.30/3. .SCI(含SCIE) |
| 47. 高喜翔，谷涌泉*.A Vascular Malformation in the Carotid Sheath at the Carotid Bifurcation Mimicking Carotid Body Tumor. .2020.54/2. .SCI(含SCIE) |
| 48. 高喜祥，李杨，孟良，佟铸，郭连瑞，郭建明，谷涌泉*.Extra-Luminal Treatment for an Internal Carotid Artery Aneurysm with Hostile Anatomic Condition. .2020.66. .SCI(含SCIE) |
| 49. 郭建明，郭连瑞*，Alan Dardik，佟铸，邢月浩，蔡志文，谷涌泉*.Analysis of 17 years of surgical treatment for chronic limb ischemia in a Chinese National Clinical Center for Geriatric Disorders (2002 to 2018). .2020.318. .SCI(含SCIE) |
| 50. 郭建明，郭连瑞*，谷涌泉*，崔世军，Alan Dardik，刘一人，佟铸.A Retrospective Comparative Study of Twelve-Month Clinical Outcomes for Drug-Coating Balloon Angioplasty and Stent Implantation in Treating Patients with Popliteal Obstructive Lesions. .2020.5(3). .SCI(含SCIE) |
| 51. 佟铸， 谷涌泉*.Effectiveness of distal arterial bypass with porcine decellularized vascular graft for treating diabetic lower limb ischemia. .2020.8(1). .SCI(含SCIE) |
| 52. 佟铸， 谷涌泉*.Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-S tent Restenosis: A Systematic Review and Meta-Analysis. .2020.2020. .SCI(含SCIE) |
| 53. 徐泽勤，谷涌泉*.Biocompatibility evaluation of heparin-conjugated poly(ε-caprolactone) scaffolds in a rat subcutaneous implantation model. .2020.31/8. .SCI(含SCIE) |
| 54. 蔡志文，谷涌泉*.Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans. .2020.64. .SCI(含SCIE) |
| 55. 谷涌泉，张成超.血管减容联合药物涂层球囊在下肢动脉硬化闭塞症病变治疗中的作用. .2020.29（6）. .CSCD |
| 56. 24. 谷涌泉 谷涌泉*，邢月浩，郭建明，管清华.近肾腹主动脉瘤的外科治疗. .2020.33（4）. .CSCD |
| 57. 张成超 谷涌泉* 张宇,张强,郭连瑞.下肢动脉再通术后缺血再灌注损伤和骨筋膜室综合征的治疗. .2020.48（12）. .CSCD |
| 58. 张成超，谷涌泉*.无名动脉狭窄或闭塞的腔内治疗. .2020.22（11）. .CSCD |
| 59. 谷涌泉.定向斑块切除联合药物涂层球囊治疗同侧锁骨下、椎动脉重度狭窄1例报告. .2019.19（5）. .CSCD |
| 60. 谷涌泉.症状性椎动脉重度狭窄的腔内治疗进展. .2019.21（12）. .CSCD |
| 61. 谷涌泉.A Randomized,Double-Blind,Placebo-Controlled PhaseII Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia. .2019.27（12）. .SCI(含SCIE) |
| 62. 谷涌泉 王飞 王蓉 李建新 王聪 李立强 徐泽勤 张建*.Preparation and evaluation of decellularized porcine carotid arteries cross-linked by genipin: the preliminary results. .2018.19(3). .SCI(含SCIE) |
| 63. 谷涌泉.定向斑块切除联合药物涂层球囊治疗椎动脉重度狭窄1 例. .2018.27（1）. .CSCD |
| 64. 谷涌泉.定向斑块切除联合药物涂层球囊治疗颈内动脉重度狭窄1例. .2018.27（6）. .CSCD |
| 65. 谷涌泉.双导丝球囊扩张联合紫杉醇灌注治疗股动脉支架再狭窄1例. .2018.27（7）. .CSCD |
| 66. 谷涌泉.中国糖尿病足诊治指南. .2017.97（4）. .CSCD |
| 67. 谷涌泉 郭连瑞 齐立行 崔世军 郭建明 高喜翔 佟铸 齐一侠 张成超 吴中俭 张建 汪忠镐.准分子激光消融联合药物球囊治疗下肢动脉慢性缺血3例. .2017.26（1）. .CSCD |
| 68. 谷涌泉 郭连瑞 郭建明 齐立行 佟 铸 崔世军 高喜翔 吴英锋 张 建 汪忠镐.SilverHawk斑块切除联合紫杉醇药物球囊治疗下肢动脉慢性缺血. .2017.17(1). .CSCD |
| 69. 谷涌泉 齐立行 郭连瑞.A comparative study of percutaneous atherectomy for femoropopliteal arterial occlusive disease. .2017.36（4）. .SCI(含SCIE) |
| 70. 谷涌泉 郭建明.下肢动脉硬化闭塞症的外科治疗现状与未来发展. .2017.19（12）. .CSCD |
| 71. 谷涌泉 郭建明.糖尿病膝下动脉病变腔内治疗的新进展. .2017.17（4）. .CSCD |
| 72. 谷涌泉 郭连瑞 郭建明 佟铸.主动脉修复术中髂内动脉保留技术. .2017.26（2）. .CSCD |
| 73. 谷涌泉，张建 ，齐立行 ，俞恒锡， 李学锋， 郭连瑞， 陈兵， 佟铸 ，郭建明 ，汪忠镐.颈部动脉血流重建治疗重症多发性大动脉炎导致脑缺血的疗效分析. .2016.18(11). .CSCD |
| 74. 谷涌泉*,郭连瑞，郭建明，崔世军，齐一侠，佟铸，张建，汪忠镐.胸主动脉覆膜支架联合八爪鱼技术腔内修复复杂胸腹主动脉瘤. .2016.25(6). .CSCD |
| 75. 谷涌泉，郭连瑞，郭建明，Alan Dardik，张淑文，佟铸，张建，汪忠镐.Granulocyte colony-stimulating factor improves the efficacy of autologous bone marrow-derived mononuclear cell transplantation treatment for lower limb ischemia.. .2016.4. .SCI(含SCIE) |
| 76. 郭建明，谷涌泉* ，郭连瑞， 佟铸， 高喜翔.Angiojet rheolytic thrombectomy combined catheter fragmentation in a patient with massive PE shock. .2016.2016,20. .SCI(含SCIE) |
| 77. 郭建明，谷涌泉*， 郭连瑞， 俞恒锡， 齐立行， 崔世军， 佟铸 ，张建 ，汪忠镐.Effects of Sarpogrelate Combined with Aspirin in Patients Undergoing Carotid Endarterectomy in China. .2016.35. .SCI(含SCIE) |
| 78. 谷涌泉，齐立行，郭连瑞，郭建明，俞恒锡，佟铸，崔世军，高喜翔，张建，汪忠镐.腔内修复治疗累及左锁骨下动脉的主动脉夹层动脉瘤. .2016.25（3）. .CSCD |
| 79. 谷涌泉*，郭连瑞，齐立行，俞恒锡，佟铸，郭建明，高喜翔，张建，汪忠镐.复杂腹主动脉瘤腔内修复65例经验. .2016.16（3）. .CSCD |
| 80. 郭建明，谷涌泉* ，郭连瑞，佟铸，武欣，张建，汪忠镐.A case mesenchymal chondrosarcoma arising from the femoral vein with8 years of follow-up. .2015.29（7）. .SCI(含SCIE) |
| 81. 郭建明，谷涌泉*，郭连瑞，佟铸，高喜翔，吴英锋，张建，汪忠镐.Turbohawk 斑块切除系统治疗下肢动脉硬化闭塞病变. .2015.24(6). .CSCD |
| 82. 谷涌泉*，郭建明，郭连瑞，佟铸，高喜翔，张建，汪忠镐.覆膜支架腔内成形治疗平肾主髂动脉闭塞1例报告. .2015.15(4). .CSCD |
| 83. 马天宇，郭连瑞，李学锋，佟铸，郭建明，谷涌泉*.下肢动脉硬化闭塞症外科治疗方法的比较及预后：单中心十年经验. .2015.53(4). .CSCD |
| 84. 佟铸，谷涌泉*，郭连瑞，郭建明，高喜翔，马天宇，刘梦霞，李建新，汪忠镐，张建.复杂锁骨下动脉闭塞性病变的腔内治疗. .2015.24(3). .CSCD |
| 85. 谷涌泉*，佟铸，郭连瑞.干细胞移植治疗下肢重度缺血. .2015.9(1). .CSCD |
| 86. 谷涌泉*.复合手术——血管疾病治疗新机遇. .2015.24(10). .CSCD |
| 87. 郭建明，李俊峰，谷涌泉*，郭连瑞，俞恒锡，齐立行，崔世军，佟铸，高喜翔，吴英锋，刘梦霞，张建，汪忠镐.内膜剥脱联合支架成形治疗颈动脉串联病变. .2015.24(10). .CSCD |
| 88. 谷涌泉，郭连瑞*，郭建明，高喜翔，张建，汪忠镐.髂内动脉重建治疗髂总动脉瘤一例. .2015.30(1). .CSCD |
| 89. 谷涌泉*.糖尿病足的治疗. .2015.22(8). .CSCD |
| 90. 郭建明，谷涌泉*，郭连瑞，佟铸，高喜翔，张建，汪忠镐.机械血栓抽吸装置AngioJet治疗髂股动脉支架内血栓形成一例.. .2015.42(2). .CSCD |
| 91. 佟铸，谷涌泉*，郭连瑞，郭建明，高喜翔，马天宇，刘梦霞，李建新，汪忠镐，张建.股动脉肱动脉联合入路在锁骨下动脉闭塞性病变腔内治疗中的应用. .2015.24(6). .CSCD |
| 92. 谷涌泉，戈小虎，郭建明，管圣，汪忠镐.一体式带膜支架修复腹主动脉假性动脉瘤继发下腔静脉瘘1例报告. .2014.14(3). .CSCD |
| 93. 谷涌泉，郭连瑞，李学锋，佟铸，郭建明，张建，汪忠镐.封堵器联合动脉旁路移植治疗外伤性无名动脉夹层动脉瘤1例报告. .2014.14(9）. .CSCD |
| 94. 谷涌泉，郭连瑞，郭建明，佟铸，武欣，高喜翔，李学锋，张建，汪忠镐.经腓动脉穿刺双球囊技术开通股浅动脉全程闭塞导致的严重下肢缺血1例报告. .2014.14(1). .CSCD |
| 95. 谷涌泉，郭连瑞，齐立行，李学锋，佟铸，武欣，郭建明，高喜翔，张建，汪忠镐.支架成形技术治疗肾腹主动脉和双髂动脉闭塞的中长期疗效. .2014.14（10）. .CSCD |
| 96. 谷涌泉.下肢动脉硬闭塞症的外科治疗. .2014.6（2）. .CSCD |
| 97. 谷涌泉.下肢动脉硬化闭塞症腔内治疗的新进展. .2014.23（6）. .CSCD |
| 98. 谷涌泉.糖尿病足缺血的腔内治疗. .2014.22（7）. .CSCD |
| 99. 谷涌泉，齐一侠.巴德-吉亚利综合征的治疗进展. .2014.27（2）. .CSCD |
| 100. 谷涌泉，齐立行，张建，郭连瑞，俞恒锡，李学锋，陈兵，佟铸，武欣，郭建明，高喜翔，汪忠镐.195例主髂动脉硬化闭塞的临床分析. .2014.16（3）. .CSCD |
| 101. 谷涌泉，武欣.3-D打印技术在血管外科的应用. .2014.28（3）. .CSCD |
| 102. GUO Lianrui# GU Yongquan* QI Lixing TONG Zhu WU Xin GUO Jianming ZHANG Jian WANG Zhonggao.Totally laparoscopic bypass surgery for aortoiliac occlusive disease in China. .2013.126(16). .SCI(含SCIE) |
| 103. GU Yongquan GUO Lianrui QI Lixing LI Xuefeng TONG Zhu CUI Shijun WU Yingfeng GUO Jianming ZHANG Jian WANG Zhonggao.Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SliverHawk atherectomy catheter. .2013.32(4). .SCI(含SCIE) |
| 104. 谷涌泉 郭建明 张建 汪忠镐.膝下动脉闭塞性病变的处理. .2013.21(5). .CSCD |
| 105. 谷涌泉 张建 郭连瑞 崔世军 李学峰 丁大有 Jong-Mook Kim Seong-Hyun Ho Sunyoung Kim.Successful treatment of spontaneous rupture of the internal carotid artery in an promyelocytic leukemia patient using ultrasound-guided thrombin injection. .2013.126(2). .SCI(含SCIE) |
| 106. 谷涌泉 郭建明 张建 汪忠镐.下肢缺血的外科治疗进展. .2013.27（2）. .CSCD |
| 107. 谷涌泉 郭连瑞 齐立行 俞恒锡 李学锋 陈兵 佟铸 武欣 郭建明 齐一侠 杨盛家 张建 汪忠镐.开腹与腔内技术治疗腹主动脉瘤的临床效果比较. .2013.93（9）. .CSCD |
| 108. 谷涌泉 郭连瑞 郭建明 佟铸 李学峰 武欣 张建 汪忠镐.下肢动脉腔内成形治疗下肢动脉旁路移植后血管闭塞导致的严重缺血. .2013.13（1）. .CSCD |
